Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | # Peptides (by Search Engine): A2 Sequest HT (IgG 293) | # Peptides (by Search Engine): B2 Sequest HT (Sel1L 293) | # Peptides (by Search Engine): C2 Sequest HT (WT 293) | # Peptides (by Search Engine): D2 Sequest HT (HKO 293) | # PSMs (by Search Engine): A2 Sequest HT (IgG 293) | # PSMs (by Search Engine): B2 Sequest HT (Sel1L 293) | # PSMs (by Search Engine): C2 Sequest HT (WT 293) | # PSMs (by Search Engine): D2 Sequest HT (HKO 293) | Abundance: F1: Sample, IgG 293 | Abundance: F2: Sample, Sel1L 293 | Abundance: F3: Sample, WT 293 | Abundance: F4: Sample, HKO 293 | Abundances Count: F1: Sample, IgG 293 | Abundances Count: F2: Sample, Sel1L 293 | Abundances Count: F3: Sample, WT 293 | Abundances Count: F4: Sample, HKO 293 | Modifications | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Ensembl Gene ID | Gene Symbol | Chromosome | Reactome Pathways | KEGG Pathways | # Razor Peptides |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medium | O75935 | Dynactin subunit 3 OS=Homo sapiens OX=9606 GN=DCTN3 PE=1 SV=1 | 0.035 | 1.23 | 5 | 1 | 1 | 1 | 186 | 21.1 | 5.47 | 1 | 1 | 330171.6563 | 125048.8672 | 162453.2813 | 1 | 1 | 1 | Met-loss+Acetyl [N-Term] | cell division;regulation of biological process;transport | chromosome;cytoplasm;cytoskeleton;cytosol | protein binding;structural molecule activity | Pf07426 | 11258 | ENSG00000137100.15 | DCTN3 | 9 | COPI-independent Golgi-to-ER retrograde traffic; Regulation of PLK1 Activity at G2/M Transition; AURKA Activation by TPX2; Anchoring of the basal body to the plasma membrane; Recruitment of NuMA to mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Loss of Nlp from mitotic centrosomes; COPI-mediated anterograde transport; MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) | 0 |